We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Fujirebio and Sysmex Collaborate for Development and Advancement of Immunoassay

By LabMedica International staff writers
Posted on 18 Dec 2023

Image: Fujirebio and Sysmex have signed an agreement for the supply of reagent raw materials in the field of immunoassay (Photo courtesy of 123RF)

Image: Fujirebio and Sysmex have signed an agreement for the supply of reagent raw materials in the field of immunoassay (Photo courtesy of 123RF)

Fujirebio Holdings (Tokyo, Japan) and Sysmex Corporation (Kobe, Japan) have signed an agreement for the mutual supply of reagent raw materials owned by both companies. The agreement is based on a basic agreement on business collaboration in the field of immunoassay signed by the two companies in October 2023.

In October 2023, Fujirebio and Sysmex entered into a basic agreement on business collaboration in the field of immunoassay, intending to promote cooperation to accelerate their global expansion, and to contribute to the development and advancement of immunoassay. To promote specific initiatives, the two companies signed a Contract Development and Manufacturing Organization (CDMO) agreement in November 2023 related to dedicated reagents for the HISCL-Series automated immunoassay system, involving the development of reagents for cerebral-spinal fluid-based and blood-based testing in the field of neurodegenerative diseases, including Alzheimer’s disease.

As per the terms of the agreement, Fujirebio and Sysmex will mutually supply a wide range of reagent materials owned by each company, primarily antigens and antibodies, which are the key raw materials of immunoassay reagents. This will allow the CDMO to speed up reagent development, lower costs, and maximize the value of raw material assets while building a stable supply system to meet the global demand growth in the future and prepare for raw material procurement risk in case of an emergency. By strengthening cooperation in the area of reagent materials, Fujirebio and Sysmex will promote the mutual utilization of their high-quality reagent materials. Additionally, they will continue to work together in the future to develop new parameters and technologies.

Related Links:
Fujirebio Holdings
Sysmex Corporation

Visit expo >

Gold Member

Serological Pipet Controller

PIPETBOY GENIUS

Verification Panels for Assay Development & QC
Seroconversion Panels

New

Troponin I Test

Quidel Triage Troponin I Test

New

Community-Acquired Pneumonia Test

RIDA UNITY CAP Bac

Latest Industry News

Channels

Clinical Chemistry

view channel

Carbon Nanotubes Help Build Highly Accurate Sensors for Continuous Health Monitoring

Current sensors can measure various health indicators, such as blood glucose levels, in the body. However, there is a need to develop more accurate and sensitive sensor materials that can detect lower... Read more

Image: The paper-based device generates high-quality samples of dried plasma, enabling accurate measurements of HIV viral load (Photo courtesy of Charlie Mace/Tufts)

Paper-Based Device Boosts HIV Test Accuracy from Dried Blood Samples

In regions where access to clinics for routine blood tests presents financial and logistical obstacles, HIV patients are increasingly able to collect and send a drop of blood using paper-based devices... Read more

AI-Powered Raman Spectroscopy Method Enables Rapid Drug Detection in Blood

Accurately monitoring drug levels in the blood is essential for effective treatment, particularly in the management of cardiovascular diseases. Traditional techniques for monitoring blood drug levels often... Read more

Image: The LC-MS/MS assay can serve as a reference method to validate emerging biosensors for renal function monitoring (Photo courtesy of 123RF)

Novel LC-MS/MS Assay Detects Low Creatinine in Sweat and Saliva

Timely and accurate monitoring of renal function is essential for managing patients at risk of acute kidney injury (AKI), which affects about 12% of hospitalized patients and up to 57% of ICU patients.... Read more

Molecular Diagnostics

view channel

Novel Cell-Based Assay Provides Sensitive and Specific Autoantibody Detection in Demyelination

Anti-myelin-associated glycoprotein (MAG) antibodies serve as markers for an autoimmune demyelinating disorder that affects the peripheral nervous system, leading to sensory impairment. Anti-MAG-IgM antibodies... Read more

Image: The low-cost test builds on existing platform that assesses COVID-19 and water quality (Photo courtesy of 123RF)

Novel Point-of-Care Technology Delivers Accurate HIV Results in Minutes

HIV diagnostic methods have traditionally relied on detecting HIV-specific antibodies, which typically appear weeks after infection. This delayed detection has hindered early diagnosis, complicating patient... Read more

Image: Specific biomarkers in the blood can predict the development of dementia (Photo courtesy of Shutterstock)

Blood Test Rules Out Future Dementia Risk

Previous studies have suggested that specific biomarkers, such as tau217, Neurofilament Light (NfL), and Glial Fibrillary Acidic Protein (GFAP), may be valuable for early dementia diagnosis.... Read more

D-Dimer Testing Can Identify Patients at Higher Risk of Pulmonary Embolism

Pulmonary embolism (PE) is a commonly suspected condition in emergency departments (EDs) and can be life-threatening if not diagnosed correctly. Achieving an accurate diagnosis is vital for providing effective... Read more

Hematology

view channel

Image: The 3-parameter CCRS model was devised specifically for patients diagnosed with clonal cytopenia (Photo courtesy of 123RF)

New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder

Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more

Image: The technology has the unique ability to detect challenging RhD variants that are typically excluded by other commercial tests (Photo courtesy of BillionToOne)

Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy

In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read more

Image: Leukocyte count represents an easily accessible, inexpensive clinical marker (Photo courtesy of 123RF)

WBC Count Could Predict Severity of COVID-19 Symptoms

The global health crisis caused by the SARS-CoV-2 virus continues to impact millions of people worldwide, with many experiencing persistent symptoms months after the initial diagnosis. Cognitive impairment... Read more

Image: The high precision platelet counting technology reduces risks that can lead to errors in cancer diagnoses (Photo courtesy of Adobe Stock)

New Platelet Counting Technology to Help Labs Prevent Diagnosis Errors

Accurate platelet count testing is a significant challenge for laboratories. Inaccurate results can lead to misdiagnosis, missed diagnoses, and delayed treatment for a variety of potentially fatal conditions,... Read more

Immunology

view channel

Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients

Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read more

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Cerebrospinal Fluid Test Predicts Dangerous Side Effect of Cancer Treatment

In recent years, cancer immunotherapy has emerged as a promising approach where the patient's immune system is harnessed to fight cancer. One form of immunotherapy, called CAR-T-cell therapy, involves... Read more

Microbiology

view channel

Image: The AI-based method can more accurately detect antibiotic resistance in deadly bacteria such as tuberculosis and staph (Photo courtesy of Adobe Stock)

New AI-Based Method Improves Diagnosis of Drug-Resistant Infections

Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more

Innovative ID/AST System to Help Diagnose Infectious Diseases and Combat AMR

Each year, 11 million people across the world die of sepsis out of which 1.3 million deaths are due to antibiotic-resistant bacteria. The burden of antimicrobial resistance (AMR) continues to weigh heavily,... Read more

Image: The QIAstat-Dx Gastrointestinal Panel 2 Mini B runs on the QIAstat-Dx system (Photo courtesy of QIAGEN)

Gastrointestinal Panel Delivers Rapid Detection of Five Common Bacterial Pathogens for Outpatient Use

Acute infectious gastroenteritis results in approximately 179 million cases each year in the United States, leading to a significant number of outpatient visits and hospitalizations. To address this, a... Read more

Pathology

view channel

AI Model Effectively Predicts Patient Outcomes in Common Lung Cancer Type

Lung adenocarcinoma, the most common form of non-small cell lung cancer (NSCLC), typically adopts one of six distinct growth patterns, often combining multiple patterns within a single tumor.... Read more

Image: The new AI model personalizes bladder cancer treatment (Photo courtesy of Shutterstock)

AI Model Predicts Patient Response to Bladder Cancer Treatment

Each year in the United States, around 81,000 new cases of bladder cancer are diagnosed, leading to approximately 17,000 deaths annually. Muscle-invasive bladder cancer (MIBC) is a severe form of bladder... Read more

Image: The new method can help accelerate the diagnosis of oncological diseases (Photo courtesy of Vilnius University)

New Laser-Based Method to Accelerate Cancer Diagnosis

Researchers have developed a method to improve cancer diagnostics and other diseases. Collagen, a key structural protein, plays various roles in cell activity. A novel multidisciplinary study published... Read more

New AI Model Predicts Gene Variants’ Effects on Specific Diseases

In recent years, artificial intelligence (AI) has greatly enhanced our ability to identify a vast number of genetic variants in increasingly larger populations. However, up to half of these variants are... Read more

Technology

view channel

Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Image: Pictorial representation of the working principle of a functionalized Carbon Dots CDs and EB based Func sensor (Photo courtesy of Toppari/University of Jyväskylä)

Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection

Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read more

Image: In ATR-FTIR spectroscopy, light bounces off a crystal and briefly touches the sample, enabling researchers to take measurements (Photo courtesy of Georgia State University)

Smartphones Could Diagnose Diseases Using Infrared Scans

Rapid advancements in technology may soon make it possible for individuals to bypass invasive medical procedures by simply uploading a screenshot of their lab results from their phone directly to their doctor.... Read more

Image: A spectroscopic image shows on-electrode molecules that drive metabolite-sensing reactions (Photo courtesy of Xuanbing Cheng and Zongqi Li/Emaminejad Lab)

Novel Sensor Technology to Enable Early Diagnoses of Metabolic and Cardiovascular Disorders

Metabolites are critical compounds that fuel life's essential functions, playing a key role in producing energy, regulating cellular activities, and maintaining the balance of bodily systems.... Read more